Bank of Montreal’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $380M | Buy |
1,926,315
+287,446
| +18% | +$55.4M | 0.14% | 130 |
|
|
2025
Q4 | $301M | Sell |
1,638,869
-100,188
| -6% | -$17.6M | 0.1% | 156 |
|
|
2025
Q3 | $267M | Buy |
1,739,057
+1,347,896
| +345% | +$204M | 0.1% | 151 |
|
|
2025
Q2 | $54.7M | Sell |
391,161
-726,385
| -65% | -$102M | 0.03% | 411 |
|
|
2025
Q1 | $164M | Buy |
1,117,546
+604,400
| +118% | +$87.4M | 0.08% | 179 |
|
|
2024
Q4 | $67.2M | Sell |
513,146
-1,022,521
| -67% | -$143M | 0.03% | 381 |
|
|
2024
Q3 | $238M | Buy |
1,535,667
+802,879
| +110% | +$130M | 0.1% | 154 |
|
|
2024
Q2 | $117M | Buy |
732,788
+192,154
| +36% | +$28.9M | 0.03% | 264 |
|
|
2024
Q1 | $73.3M | Sell |
540,634
-224,128
| -29% | -$29.7M | 0.02% | 353 |
|
|
2023
Q4 | $103M | Buy |
764,762
+157,867
| +26% | +$20.5M | 0.03% | 293 |
|
|
2023
Q3 | $83.4M | Sell |
606,895
-477,701
| -44% | -$65.2M | 0.03% | 296 |
|
|
2023
Q2 | $163M | Buy |
1,084,596
+125,302
| +13% | +$18.4M | 0.06% | 174 |
|
|
2023
Q1 | $133M | Sell |
959,294
-285,533
| -23% | -$38.4M | 0.05% | 194 |
|
|
2022
Q4 | $169M | Buy |
1,244,827
+357,349
| +40% | +$44.8M | 0.07% | 154 |
|
|
2022
Q3 | $97.6K | Buy |
887,478
+367,172
| +71% | +$46.6M | 0.04% | 242 |
|
|
2022
Q2 | $68.6K | Sell |
520,306
-128,102
| -20% | -$16.8M | 0.03% | 314 |
|
|
2022
Q1 | $87.1M | Sell |
648,408
-276,713
| -30% | -$33.2M | 0.04% | 304 |
|
|
2021
Q4 | $108M | Buy |
925,121
+62,593
| +7% | +$7.37M | 0.06% | 250 |
|
|
2021
Q3 | $103M | Sell |
862,528
-1,896,745
| -69% | -$221M | 0.05% | 332 |
|
|
2021
Q2 | $332M | Buy |
2,759,273
+1,958,130
| +244% | +$215M | 0.17% | 112 |
|
|
2021
Q1 | $79.3M | Sell |
801,143
-77,085
| -9% | -$7.75M | 0.05% | 310 |
|
|
2020
Q4 | $88.8M | Sell |
878,228
-42,526
| -5% | -$4.5M | 0.06% | 277 |
|
|
2020
Q3 | $98.9M | Buy |
920,754
+7,642
| +0.8% | +$850K | 0.08% | 199 |
|
|
2020
Q2 | $98.6M | Sell |
913,112
-15,730
| -2% | -$1.62M | 0.09% | 190 |
|
|
2020
Q1 | $81.3M | Sell |
928,842
-253,149
| -21% | -$23.8M | 0.09% | 182 |
|
|
2019
Q4 | $118M | Sell |
1,181,991
-175,462
| -13% | -$16.5M | 0.09% | 200 |
|
|
2019
Q3 | $121M | Sell |
1,357,453
-2,133
| -0.2% | -$185K | 0.1% | 172 |
|
|
2019
Q2 | $112M | Buy |
1,359,586
+62,172
| +5% | +$4.87M | 0.09% | 187 |
|
|
2019
Q1 | $105M | Buy |
1,297,414
+290,569
| +29% | +$22.9M | 0.09% | 199 |
|
|
2018
Q4 | $76.5M | Buy |
1,006,845
+65,868
| +7% | +$5.14M | 0.07% | 232 |
|
|
2018
Q3 | $74.5M | Buy |
940,977
+485,428
| +107% | +$36.7M | 0.06% | 285 |
|
|
2018
Q2 | $32M | Buy |
455,549
+140,192
| +44% | +$10.1M | 0.03% | 469 |
|
|
2018
Q1 | $22.1M | Buy |
315,357
+107,794
| +52% | +$7.47M | 0.02% | 581 |
|
|
2017
Q4 | $14.4M | Buy |
207,563
+146,123
| +238% | +$9.85M | 0.01% | 731 |
|
|
2017
Q3 | $4.16M | Sell |
61,440
-120,341
| -66% | -$7.6M | ﹤0.01% | 1252 |
|
|
2017
Q2 | $12.4M | Buy |
181,781
+123,236
| +210% | +$8.05M | 0.01% | 760 |
|
|
2017
Q1 | $3.65M | Sell |
58,545
-13
| -0% | -$757 | ﹤0.01% | 1216 |
|
|
2016
Q4 | $3.06M | Sell |
58,558
-6,570
| -10% | -$373K | ﹤0.01% | 1307 |
|
|
2016
Q3 | $4.28M | Sell |
65,128
-8,678
| -12% | -$567K | ﹤0.01% | 1160 |
|
|
2016
Q2 | $4.46M | Buy |
73,806
+1,253
| +2% | +$72.8K | 0.01% | 1139 |
|
|
2016
Q1 | $4.09M | Buy |
72,553
+227
| +0.3% | +$13.6K | ﹤0.01% | 1111 |
|
|
2015
Q4 | $4.91M | Buy |
72,326
+29,643
| +69% | +$1.94M | 0.01% | 1004 |
|
|
2015
Q3 | $2.71M | Sell |
42,683
-3,596
| -8% | -$237K | ﹤0.01% | 1176 |
|
|
2015
Q2 | $2.95M | Sell |
46,279
-5,944
| -11% | -$407K | ﹤0.01% | 1239 |
|
|
2015
Q1 | $3.57M | Sell |
52,223
-5,563
| -10% | -$387K | ﹤0.01% | 1148 |
|
|
2014
Q4 | $4.07M | Sell |
57,786
-8,387
| -13% | -$601K | ﹤0.01% | 1116 |
|
|
2014
Q3 | $4.73M | Sell |
66,173
-16,793
| -20% | -$1.23M | 0.01% | 1110 |
|
|
2014
Q2 | $6.17M | Sell |
82,966
-115,894
| -58% | -$8.38M | 0.01% | 1014 |
|
|
2014
Q1 | $12.9M | Sell |
198,860
-28,248
| -12% | -$1.82M | 0.02% | 565 |
|
|
2013
Q4 | $13.5M | Sell |
227,108
-14,602
| -6% | -$793K | 0.02% | 497 |
|
|
2013
Q3 | $12.6M | Sell |
241,710
-23,400
| -9% | -$1.18M | 0.02% | 460 |
|
|
2013
Q2 | $12.5M | Buy |
+265,110
| New | +$13.5M | 0.02% | 427 |
|
Other funds holding AZN
IA
VCM
VAM
Bank of Montreal's AZN Position: Q1 2026 in Review
Bank of Montreal increased its AstraZeneca (AZN) stake by 18% in Q1 2026, buying an estimated $55.4M and bringing the position to 1,926,315 shares worth $380M. The position accounts for 0.14% of the portfolio, ranked #130.
Bank of Montreal first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Bank of Montreal held 1,926,315 shares of AstraZeneca worth $380M as of Q1 2026.
- Bank of Montreal bought 287,446 AstraZeneca shares in Q1 2026, an estimated $55.4M.
- AstraZeneca made up 0.14% of Bank of Montreal's portfolio in Q1 2026, its #130 holding.
- Bank of Montreal first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.